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Introduction {#sec1}
============

Lysosomes are cellular organelles primarily involved in degradation and recycling processes ([@bib20]). Lysosomes are also involved in a secretory pathway known as lysosomal exocytosis, which requires two sequential steps. In the first step, Ca^2+^-independent ([@bib17]), lysosomes are recruited to the close proximity of the cell surface, while in the second step the pool of predocked lysosomes fuse with the plasma membrane (PM) in response to Ca^2+^ elevation ([@bib1; @bib17; @bib41]). Lysosomal exocytosis plays a major role in several physiological processes such as cellular immune response, bone resorption, and PM repair ([@bib1; @bib2; @bib9]). Ca^2+^-dependent lysosomal exocytosis was considered to be limited to specialized secretory cells; however, recent studies indicate that this process occurs in all cell types ([@bib1; @bib34; @bib35]). Although the main steps of lysosomal exocytosis have been elucidated, little is known about its regulation and how this process is coordinated with lysosomal biogenesis.

We recently discovered that lysosomal biogenesis and lysosomal degradative function are transcriptionally regulated by the bHLH-leucine zipper transcription factor EB (TFEB) ([@bib37]). TFEB activation was able to reduce the accumulation of the pathogenic protein in a cellular model of Huntington disease ([@bib37]) and ameliorated the phenotype of cells from a murine model of Parkinson disease ([@bib12]).

In this study we demonstrated that TFEB transcriptionally regulates lysosomal exocytosis both by inducing the release of intracellular Ca^2+^ through its target gene MCOLN1 and by increasing the population of lysosomes ready to fuse with the PM. Moreover, we demonstrated that the induction of lysosomal exocytosis by TFEB promotes cellular clearance in pathological conditions such as lysosomal storage diseases (LSDs) in which the lysosomal degradative capacity of cells is compromised.

Results and Discussion {#sec2}
======================

TFEB Overexpression Induces Lysosomal Exocytosis {#sec2.1}
------------------------------------------------

A typical hallmark of lysosomal exocytosis is the translocation of lysosomal membrane markers to the PM ([@bib33; @bib35; @bib43]). TFEB overexpression in mouse embryonic fibroblasts (MEFs) and neuronal stem cells (NSCs) resulted in an increased exposure of the luminal domain of LAMP1, a lysosomal membrane marker, on the PM ([Figure 1](#fig1){ref-type="fig"}A). Consistently, quantitative analysis by flow cytometry (FACs) showed an increase of LAMP1 staining on the PM of TFEB-overexpressing cells ([Figure 1](#fig1){ref-type="fig"}B). A direct consequence of lysosomal exocytosis is the release of lysosomal enzymes into the cell culture medium ([@bib35]). Significantly higher levels of lysosomal hydrolases were detected in the medium of several cells lines overexpressing TFEB compared with control cells ([Figure 1](#fig1){ref-type="fig"}C). The increase of lysosomal enzymes in the medium was not associated with an increase in the levels of cytosolic lactate dehydrogenase (LDH), thus excluding that the release of lysosomal enzymes was due to cell damage (see [Figure S1](#app2){ref-type="sec"}A available online). Together, these data indicate that TFEB induces lysosomal exocytosis.

Western blot and FACs analyses revealed an enrichment of LAMP1 on the PM compared with total LAMP1 in TFEB-overexpressing cells, suggesting that the elevation of LAMP1 on the PM was not a mere consequence of TFEB-mediated expansion of the lysosomal compartment and of the consequent increase of LAMP1 protein levels ([@bib37]), but it reflected an active movement of lysosomes toward the PM ([Figures 1](#fig1){ref-type="fig"}D and 1E).

To exclude the possibility that TFEB-mediated induction of LAMP1 expression resulted in an overloading of the trans-Golgi network (TGN) with a consequent abnormal sorting of LAMP1 directly from the TGN to the PM, we performed experiments using the temperature-sensitive VSVG-GFP protein ([Figure S1](#app2){ref-type="sec"}B). This approach is generally used to monitor transport through the TGN-to-PM segment of the secretory pathway ([@bib24]). At 20°C, both control and stable HeLa cells expressing TFEB (CF7 cells) exhibited the VSVG protein trapped in the Golgi area, while the staining for LAMP1 decorated a different compartment with a typical spotty lysosome-like pattern ([Figure S1](#app2){ref-type="sec"}B, left panel arrows). This indicates that the exposure to the low temperature did not cause the accumulation of a detectable amount of newly synthesized LAMP1 within the Golgi, despite overexpression of TFEB. The temperature shift from 20°C to 37°C triggered VSVG exit from the Golgi toward the PM ([Figure S1](#app2){ref-type="sec"}B, middle panel arrows), while again no VSVG overlap with LAMP1 was detected within intracellular structures directed toward the cell surface. Finally, blocking fusion of Golgi-derived VSVG transport carriers with the PM ([@bib31]; see also [Experimental Procedures](#sec3){ref-type="sec"}) by the use of 0.5% tannic acid (TA) resulted in the accumulation of VSVG transport carriers near the PM ([Figure S1](#app2){ref-type="sec"}B, right panel arrows), as expected. However, no LAMP1 was detected within such VSVG-positive structures, suggesting that LAMP1 was not delivered to the PM from the Golgi in CF7 cells. These results clearly indicate that LAMP1 does not escape the lysosomal route in TFEB-overexpressing cells and support our conclusion that the increase of LAMP1 on the PM is due to enhanced lysosomal exocytosis.

TFEB Overexpression Enhances Lysosomal Predocking to the PM and Elevates Intracellular Ca^2+^ {#sec2.2}
---------------------------------------------------------------------------------------------

Induction of lysosomal exocytosis involves the recruitment of lysosomes to the PM ([@bib8]). TFEB overexpression resulted in an increased motility of lysosomes ([Figure 2](#fig2){ref-type="fig"}A; [Movies 1 and 2](#mmc2 mmc3){ref-type="supplementary-material"}). The impact of TFEB overexpression on lysosomal recruitment was investigated using the immuno-EM approach. To this end, control HeLa and CF7 cells were labeled with an antibody against LAMP1 and prepared for ultrastructural analysis, as previously described ([@bib30]). In thin sections, LAMP1 was detected at vacuolar structures that contained multiple intralumenal vesicles and/or electron-dense material. These structures could be identified as lysosomes on the basis of their ultrastructural features ([Figure 2](#fig2){ref-type="fig"}B, arrows and arrowheads). In HeLa control cells, lysosomes were distributed randomly throughout the cells, often at a substantial distance from the cell surface ([Figure 2](#fig2){ref-type="fig"}B, upper left panel and arrows). To reveal the pool of lysosomes that undergo exocytosis, we incubated cells for 1 hr in the medium containing 0.5% TA, which is widely used as a tool to block fusion of the different exocytic organelles with the PM ([@bib26; @bib31]). After the incubation with TA, the cells were fixed and processed for immuno-EM. Exposure of control HeLa cells to TA induced a moderate increase in LAMP1-positive structures located very close (within 200-400 nm) to the cell surface ([Figure 2](#fig2){ref-type="fig"}B, upper right panel, arrowhead and frequency plot), indicating that only a small proportion of the lysosomes underwent exocytosis over the treatment period. In contrast, CF7 cells exhibited numerous lysosomes in the close proximity of the PM ([Figure 2](#fig2){ref-type="fig"}B, middle and lower left panels, arrowheads, and frequency plot), even in the absence of TA. Block of fusion by TA further increased the pool of the LAMP1-positive structures near the cell surface, with many of them being almost attached to the PM ([Figure 2](#fig2){ref-type="fig"}B, middle and lower right panels, arrowheads, and frequency plot). It is important to note that the vast majority of such LAMP1 structures in TA-treated CF7 cells resembled lysosomes rather than Golgi-derived vesicles, in terms of both size and ultrastructural features. Notably, the magnitude of such an increase in the frequency of PM-associated lysosomes upon the block of fusion was significantly higher in TFEB-overexpressing cells compared with the control HeLa line ([Figure 2](#fig2){ref-type="fig"}B, frequency plot).

We further confirmed the latter results by loading control and TFEB-overexpressing HeLa cells with BSA gold (5 nm) for 30 min and chasing them in BSA gold--free medium for 120 min ([Figure S2](#app2){ref-type="sec"}). In these conditions, all of the endosomal structures that present BSA gold are late endosomes/lysosomes ([@bib27]). In CF7 cells, the distance between the endo/lysosomes structures and the PM was strongly reduced (mean distance HeLa control 2387nm versus 438nm in HeLa CF7) when the total number of endo/lysosomes (58 versus 73) was increased ([Figure S2](#app2){ref-type="sec"}). Notably, fusion of lysosomes with the PM and release of BSA-stained lysosomes in the extracellular space were detected in TFEB-overexpressing cells ([Figure S2](#app2){ref-type="sec"}, lower right panel). Thus, taken together, these findings indicate that TFEB overexpression significantly stimulates the recruitment of lysosomes to the PM, a step that is required for lysosomal exocytosis.

Previous studies demonstrated the requirement Ca^2+^ elevation for the fusion of lysosomes with the PM but not for the recruitment of lysosomes to the cell surface ([@bib1; @bib17; @bib35]). Confocal imaging showed an elevation of intracellular Ca^2+^ levels in TFEB-GFP-positive cells ([Figure 3](#fig3){ref-type="fig"}A), consistent with the role of TFEB in the induction of lysosomal exocytosis. To quantify the extent of TFEB-mediated Ca^2+^ elevation, we measured the cytoplasmic concentration of Ca^2+^ by a ratiometric assay ([@bib18]). We observed a very significant increase in Ca^2+^ concentration in TFEB-overexpressing CF7 HeLa cells compared with control cells (91.4 nM ± 1.1 and 67.5 nM ± 0.8, respectively) ([Figure 3](#fig3){ref-type="fig"}B). Moreover, depletion of Ca^2+^ by the use of Ca^2+^ chelators in TFEB-overexpressing cells completely inhibited the appearance of LAMP1 on PM ([Figure 3](#fig3){ref-type="fig"}C). As expected, TFEB-mediated recruitment of lysosomes to the PM, as measured by EM analysis of the distance of the endo-lysosomes structures to the PM in BSA gold-loaded cells, was not affected by depletion of Ca^2+^ in CF7 cells ([Figure 3](#fig3){ref-type="fig"}D).

Together, these results indicate that in addition to promoting lysosomal recruitment to the PM, TFEB induces lysosomal exocytosis by enhancing Ca^2+^-mediated fusion of lysosomes with the PM.

TFEB Releases Ca^2+^ from Acidic Stores through the Activation of Mucolipin-1 {#sec2.3}
-----------------------------------------------------------------------------

Mucolipin 1 (MCOLN1) is a lysosomal nonselective cation channel that is mutated in mucolipidosis IV (MLIV), a severe type of LSD ([@bib4; @bib5; @bib6]). Previous studies reported that lysosomal exocytosis is reduced in MLIV cells ([@bib21]) and increased in cells expressing gain-of-function MCOLN1 mutations ([@bib14]). These observations suggest that MCOLN1, upon a proper cellular stimulation, mediates intralysosomal Ca^2+^ release to trigger lysosomal exocytosis. In a separate study, we demonstrated that the gene encoding MCOLN1 is regulated by TFEB ([@bib44]), making it an appealing candidate to mediate TFEB effects on lysosomal exocytosis. Remarkably, TFEB-mediated increase of intracellular Ca^2+^ was blocked in CF7 cells and in NSCs overexpressing TFEB by transient silencing of MCOLN1 with a pool of four fluorescently tagged vectors carrying specific MCOLN1-shRNAs ([Figures 4](#fig4){ref-type="fig"}A and 4B). Confocal Ca^2+^ imaging of HeLa cells stably depleted for MCOLN1 using a single shRNA vector (HeLa^shMCOLN1^) failed to detect an elevation of intracellular Ca^2+^ in TFEB-overexpressing cells ([Figure 4](#fig4){ref-type="fig"}C). Consistently, Ca^2+^ levels were not affected by TFEB overexpression in human MLIV cells that carry loss of function mutations of MCOLN1 ([Figure 4](#fig4){ref-type="fig"}D). In addition, stable depletion of MCOLN1 in HeLa cells ([Figure 4](#fig4){ref-type="fig"}E) or transient depletion by a pool of shRNA vectors against MCOLN1 ([Figure 4](#fig4){ref-type="fig"}F) impaired TFEB-mediated fusion of LAMP1 with the PM, and inhibited the secretion of lysosomal enzymes into the medium ([Figure 4](#fig4){ref-type="fig"}G). Similar results were obtained by transient expression of individual shRNAs against MCOLN1 ([Figure S3](#app2){ref-type="sec"}A). To exclude off-target effects of shRNA contructs, we performed a rescue experiment using a vector carrying an shRNA-resistant mutant form of MCOLN1 (MCOLN1 mut) ([@bib42]). Overexpression of MCOLN1 mut in HeLa^shMCOLN1^ significantly recovered the appearance of surface of LAMP1 after TFEB overexpression ([Figure S3](#app2){ref-type="sec"}B).

The lysosomal localization of MCOLN1 and its channel properties suggest that the elevation of intracellular Ca^2+^ levels induced by TFEB overexpression is due to the release of Ca^2+^ from lysosomal stores through MCOLN1. To test this hypothesis, we measured cytosolic Ca^2+^ levels in TFEB-overexpressing cells by confocal imaging time-lapse after inducing acidic Ca^2+^ release with Bafilomycin A, an inhibitor of the vacuolar H^+^-ATPase, which is responsible for the proton gradient driving lysosomal Ca^2+^ uptake ([@bib10]). The results clearly showed a local increase of cytosolic Ca^2+^ levels in the stable HeLa-CF7 clone, in the transiently transfected TFEB-GFP overexpressing HeLa cells and in HeLa cells infected with an adenovirus encoding MCOLN1 ([Figure S3](#app2){ref-type="sec"}C), compared with control HeLa cells. Conversely, HeLa cells stably depleted of MCOLN1 were not able to increase Ca^2+^ levels after TFEB-GFP overexpression ([Figure S3](#app2){ref-type="sec"}C). Notably, both TFEB and MCOLN1 overexpressing cells were less sensitive to Bafilomycin A1-dependent depletion of lysosomal Ca^2+^ compared with HeLa control cells ([Figure S3](#app2){ref-type="sec"}D). Together these data strongly suggest that MCOLN1-dependent release of Ca^2+^ from acidic Ca^2+^ stores plays a major role in TFEB-mediated lysosomal exocytosis.

TFEB-Mediated Lysosomal Exocytosis Promotes Cellular Clearance in Cellular Models of LSDs {#sec2.4}
-----------------------------------------------------------------------------------------

LSDs are monogenic disorders characterized by the progressive accumulation of undegraded material in the lysosomes due to the deficiency of specific lysosomal proteins ([@bib13; @bib25]). This is often associated with intracellular trafficking abnormalities and with a block of the autophagic pathway, leading to a progressive multisystemic phenotype that is often associated with neurodegeneration ([@bib3; @bib15; @bib16; @bib29; @bib40]). Interestingly, a previous study reported induction of lysosomal exocytosis in metachromatic leukodystrophy, a neurodegenerative form of LSD ([@bib19]). We tested whether TFEB-induced lysosomal exocytosis could be exploited to induce cellular clearance in multiple sulfatase deficiency (MSD) and mucopolysaccharidosis type IIIA (MPS-IIIA), two different types of LSDs with a severe neurodegenerative outcome due to the progressive accumulation of glycosaminoglycans (GAGs) and severe vacuolization in postmitotic neurons and glial cells ([@bib29; @bib16]).

Overexpression of TFEB in MEFs derived from the murine models of MSD and MPSIIIA resulted in an even more significant increase of LAMP1 on the PM ([Figure S4](#app2){ref-type="sec"}A) and of lysosomal enzymes into the culture medium ([Figure S4](#app2){ref-type="sec"}B), compared with that observed in control cells overexpressing TFEB. This indicates that LSD cells efficiently respond to TFEB-mediated induction of lysosomal exocytosis. Therefore, we evaluated the effect of TFEB overexpression on the clearance of GAGs in glia-differentiated neuronal stem cells (NSCs) isolated from mouse models of MSD and MPSIIIA. TFEB overexpression resulted in a striking reduction of alcian blue-stained GAGs in both MSD and MPSIIIA NSC-derived glial cells ([Figure 5](#fig5){ref-type="fig"}A). The latter result was further confirmed by pulse-and-chase experiments using H^3^-glucosamine to label GAGs, showing a significant reduction of the levels of labeled GAGs after 48 hr of chase in both MSD and MPSIIIA NSC-derived glial cells overexpressing TFEB ([Figure 5](#fig5){ref-type="fig"}B). Finally, EM analysis revealed that TFEB-mediated clearance of GAGs in TFEB-overexpressing MSD and MPS-IIIA cells was associated with both significant reduction of cellular vacuolization and recovery of normal cellular morphology ([Figure 5](#fig5){ref-type="fig"}C).

The involvement of Ca^2+^ in TFEB-mediated reduction of pathologic storage was confirmed by the inhibition of GAG clearance after the addition of BAPTA to TFEB overexpressing NSCs ([Figure S4](#app2){ref-type="sec"}C). Consistent with this observation, viral-mediated overexpression of MCOLN1 in MSD glia-differentiated NSCs reduced GAG accumulation, but to a lesser extent compared with TFEB ([Figure S4](#app2){ref-type="sec"}D), suggesting that Ca^2+^ elevation is required but not sufficient to mediate TFEB effects on lysosomal exocytosis.

We extended these studies to other types of LSDs associated with the storage of different types of lysosomal substrates. Neuronal ceroid lipofuscinoses (NCL) and glycogenosis are characterized by the accumulation of lipofuscin and glycogen, respectively ([@bib7; @bib28; @bib36]). We found that TFEB overexpression strongly reduced lipofuscin autofluorescence in cells from a murine model of a juvenile form of NCL, known as Batten disease, due to mutations of the CLN3 gene ([Figure 5](#fig5){ref-type="fig"}D). Similarly, the accumulation of glycogen labeled with the exogenous fluorescent sugar 2-NBDG ([@bib22]) was significantly reduced upon TFEB overexpression in fibroblasts from a patient affected by glycogenosis type II, Pompe disease ([Figure 5](#fig5){ref-type="fig"}E). However, TFEB overexpression in mucolipidosis IV due to mutations in the MCOLN1 gene failed to induce cellular clearance, consistent with the involvement of MCOLN1 in TFEB-mediated induction of lysosomal exocytosis and clearance ([Figure S4](#app2){ref-type="sec"}E). These data indicate that induction of lysosomal exocytosis promotes cellular clearance in diseases due to accumulation of different types of lysosomal substrates. Notably, all four diseases tested (i.e., MSD, MPS-IIIA, Batten, and NCL) are due to deficiency of proteins whose activity is involved in crucial steps of different catabolic pathways. In addition, the cells analyzed were derived from patients and murine models carrying either null mutations or mutations that severely inactivate protein function. Therefore, it is unlikely that clearance of lysosomal substrates in these cells is due to either the enhancement of the activity of the defective enzymes, or to an overall induction of lysosomal catabolic processes, again suggesting that clearance is mediated by exocytosis. This was confirmed by the observation of an increase in GAG secretion, measured by H^3^-GAG, in cell culture medium from MSD cells upon TFEB overexpression ([Figure 5](#fig5){ref-type="fig"}F).

TFEB Delivery Rescues Tissue Pathology in a Mouse Model of MSD {#sec2.5}
--------------------------------------------------------------

We tested whether in vivo overexpression of TFEB in a mouse model of MSD, a severe type of LSD, had similar effects on cellular clearance. To this end, we injected systemically an adeno-associated type 2/9 virus (AAV2/9) that carries TFEB-3xflag into adult MSD mice. One month after injection, several tissues were collected to monitor transduction efficiency and GAG storage. AAV-mediated TFEB delivery resulted in efficient TFEB transduction ([Figure S5](#app2){ref-type="sec"}) and significant reduction of GAG staining in liver and skeletal muscles, as detected by alcian blue staining ([Figure 6](#fig6){ref-type="fig"}A) and GAG quantification ([Figure 6](#fig6){ref-type="fig"}B). Subsequently, we investigated whether TFEB-mediated clearance of GAGs resulted in the reduction of the pathologic hallmarks of MSD, such as macrophage infiltration and apoptosis ([@bib39]). We found a striking reduction of CD68-positive cells in AAV-TFEB injected MSD mice compared with untreated mice ([Figure 6](#fig6){ref-type="fig"}C). Most importantly, we also observed a significant reduction of TUNEL-positive cells ([Figure 6](#fig6){ref-type="fig"}D). These results indicate that TFEB activation of lysosomal exocytosis reduced both primary accumulation of GAGs and secondary pathological processes associated with LSDs such as inflammation and cell death.

Conclusions {#sec2.6}
-----------

This study demonstrates that lysosomal exocytosis is transcriptionally regulated by TFEB, a master gene for lysosomal biogenesis and autophagy ([@bib37; @bib45]). TFEB modulates lysosomal exocytosis by triggering intracellular Ca^2+^ elevation through the cation-channel MCOLN1. Cells may use this mechanism to coordinate lysosomal catabolic and secretory functions in response to specific stimuli. Our data also indicate that lysosomal exocytosis can be exploited to promote cellular clearance in lysosomal storage diseases, suggesting an alternative strategy to treat disorders due to intracellular storage, such as LSDs and common neurodegenerative diseases. Several approaches, such as gene delivery, pharmacological induction of TFEB, and target gene activation, could be exploited to promote cellular clearance in target tissues. These strategies will have to be tested by long-term in vivo studies in animal models to verify the therapeutic potential of this discovery.

Experimental Procedures {#sec3}
=======================

Cell Culture, Transfection, and VSV Infection {#sec3.1}
---------------------------------------------

HeLa, Cos7 cells, human fibroblasts, and mouse embryonic fibroblasts from mouse models of MLIV (S7), MPSIIIA (S7), and MSD were transfected using PolyFect Transfection Reagent (QIAGEN, Hilden, Germany) or lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA), according to the manufacturer\'s protocols. TFEB-3xFLAG HeLa stable cell lines (CF7) was previously described ([@bib37]). The shMCOLN1 HeLa cell line was generated by infection with MCOLN1 lentiviral shRNA. Neuronal progenitor cells were isolated from cortices of WT and MSD and MPSIIIA pups (P0) by using standard protocols (see [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details). NSCs were transfected by using nucleofection (Amaxa, Lonza, Walkersville, MD). Infection of control and CF7 HeLa cells with tsO45 strain of VSV was executed as described ([@bib30]).

Tannic Acid Treatment {#sec3.2}
---------------------

To prevent fusion of exocytic organelles with PM, control and CF7 HeLa cells were incubated for 1 hr at 37°C in 20 mM HEPES-buffered DMEM supplemented with 0.5% tannic acid (TA). At the end of the incubation, TA-containing medium was removed and cells were fixed and processed for immuno-EM (see below). For immunofluorescense (IF) experiments VSV-infected cells were exposed subsequently to 40°C and 20°C temperature blocks to accumulate VSVG first in the ER and then in the Golgi. Then cells were shifted to 37°C to activate VSVG transport from the Golgi either in the presence or in the absence of 0.5% TA. One hour after the temperature shift to 37°C, the cells were fixed and processed for (IF) labeling (see below).

Surface LAMP1 Analysis {#sec3.3}
----------------------

Cells (collected in phosphate-buffered saline \[PBS\] or grown on coverslips) were incubated with anti-rat LAMP1-1DB4 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at 4°C for 30 min. Cells were washed in PBS and fixed in 2% paraformaldehyde (PFA). Anti-LAMP1-1D4B--treated cells were further incubated with Alexa-594 conjugated anti--rat secondary antibodies (Molecular Probes, Invitrogen) for 30 min at room temperature. Finally, cells were analyzed on a confocal microscope (LSM510; Carl Zeiss, Inc., Thornwood, NY) equipped with Plan-Neofluar 63x immersion objective or on a FACs Aria Flow Cytometer (Becton Dickinson & Co., Mountain View, CA).

Immunofluorescence and Confocal Imaging {#sec3.4}
---------------------------------------

Transfected cells were grown on glass coverslips fixed with 4% paraformaldehyde (PFA, Sigma, St. Louis, MO), quenched with 50 mM NH4Cl, and permeabilized in blocking buffer (0.05% saponin/0.2% BSA in PBS/Ca/Mg). Coverslips were then incubated with appropriate primary antibodies described in [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Tissues were fixed with 4% PFA and then subjected to a sucrose gradient (from 10 to 30%), before OCT embedding. Immunofluorescence analyses were performed on 10-μm-thick serial cryosections using appropriate primary antibodies (see [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details). The secondary antibodies were purchased from Molecular Probes (Invitrogen).

Images were taken on Vectashield mounted coverslips or sections using a confocal microscope (LSM510; Carl Zeiss, Inc.) equipped with a Plan-Neofluar 63x immersion objective (Carl Zeiss, Inc.).

Immunoblot and PM Isolation {#sec3.5}
---------------------------

PM proteins were isolated using the Cell Surface Protein Isolation kit (Pierce, Thermo Fischer Scientific Inc, Rockford, IL). Immunoblots were performed using standard protocols and primary antibodies as described in [Supplemental Experimental Procedures](#app2){ref-type="sec"}. Proteins were quantified by the Bradford method.

Electron Microscopy and Immuno-Gold Analysis {#sec3.6}
--------------------------------------------

Control and TFEB-overexpressing cells (both intact and TA-treated) were washed in PBS, and fixed in 0.05% glutaraldehyde dissolved in 0.2 M HEPES buffer (pH 7.4) for 30 min at room temperature. The cells were then postfixed for 2 hr in OsO4. After dehydration in graded series of ethanol, the cells were embedded in Epon 812 (FLUKA) and polymerized at 60°C for 72 hr. Thin sections were cut at the Leica EM UC6 and counterstained with uranyl acetate and lead citrate.

For immuno-gold HeLa and CF cells (both intact and TA-treated) were fixed with a mixture of 4% paraformaldehyde and 0.05% glutaraldehyde, labeled with a monoclonal antibody against LAMP1 according the gold-enhance protocol, embedded in Epon-812, and cut as described previously ([@bib30]).

EM images were acquired from thin sections using a Philips Tecnai-12 electron microscope equipped with an ULTRA VIEW CCD digital camera (Philips, Eindhoven, The Netherlands).

Quantification of vacuolization was performed using the AnalySIS software (Soft Imaging Systems GmbH, Muenster, Germany).

Evaluation of lysosome distance from the PM was done in EM images using the iTEM software (Soft Imaging Systems GmbH).

Selection of cells for quantification was based on their suitability for stereologic analysis, i.e., only cells sectioned through their central region (detected on the basis of the presence of Golgi membranes) were analyzed.

BSA-Gold {#sec3.7}
--------

Electron microscopy and BSA immunogold were performed on HeLa control cells and overexpressing TFEB (CF7) according to the protocol described previously ([@bib32]). See [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details.

Calcium Measurements by Confocal Imaging {#sec3.8}
----------------------------------------

TFEB-GFP-transfected cells were treated with FuraRed and analyzed according to the protocol described previously ([@bib23]).

Measurements of Ca^2+^ Concentration by Ratiometric Assays {#sec3.9}
----------------------------------------------------------

HeLa cells were infected with either control adenovirus (Ad. Null) or adenovirus expressing TFEB (Ad. TFEB-FLAG). After 24 hr, cells were loaded with 20 μM Fura-2AM (Invitrogen) for 1 hr at 37°C. After washing, pseudocolor ratiometric images were acquired. The acquisition and analysis of the images were done using MetaFluor software (Molecular Devices, Sunnyvale, CA). Fura-2AM ratios (F340/F380) from cells infected with Ad. Null (n = 2584; where n represent the number of cells) or Ad. TFEB-FLAG (n = 2238) were used to calculate the cytoplasmic calcium concentration by using Fura-2AM calibration curves (see [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details).

Flow Cytometric Calcium Flux Assay {#sec3.10}
----------------------------------

The assay was performed following the protocol described by [@bib38] with some modifications as described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Enzymatic Activities {#sec3.11}
--------------------

Enzyme activities were measured using the appropriate fluorimetric or colorimetric substrates as described in [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Live Imaging {#sec3.12}
------------

Live imaging was performed on WT and CF7 cells using a Carl Zeiss microscope (LSM 710) equipped with a perfusion, open and closed cultivation chamber fitted with a Tempcontrol and CO2-control device (Y module; Carl Zeiss). Acquisition was performed using ZEISS LSM 710 software. The trajectory and the mean velocity of vesicles were calculated by IMAGEJ using the LSM reader and particle tracking plug-ins. For details, see [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

GAG Analysis {#sec3.13}
------------

GAGs were radiolabeled using H^3^-glucosamine hydrochloride (Perkin Elmer, 37.75 Ci/mmol, Boston, MA). Quantitative GAG analysis was performed according protocols described in ([@bib11]).

Alcian Blue Staining {#sec3.14}
--------------------

Sections of paraffin-embedded tissues were stained with 1% Alcian blue (Sigma-Aldrich) and counterstained with Nuclear-Fast red (Sigma-Aldrich). See [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details.

In Situ Detection of Apoptotic Cells {#sec3.15}
------------------------------------

TUNEL was performed by using the ApopTag Peroxidase In Situ Apoptosis Detection kit (Oncor, Gaithersburg, MD).

Supplemental Information {#app2}
========================

Document S1. Five Figures and Supplemental Experimental ProceduresMovie S1. Lysosomal Dynamics of a Stable HeLa Clone Expressing the Empty Vector PCDNA3 (HeLa-PCDNA3)Lysosomal movement was followed by live imaging in control HeLa-PCDNA3 cells transfected with a vector encoding the lysosomal membrane protein LAMP1 fused to GFP.Movie S2. TFEB Increases Lysosomal DynamicsThe movement of lysosomes was followed by live imaging in a stable HeLa clone expressing TFEB (HeLa-CF7 cells), and transfected with a vector encoding the lysosomal membrane protein LAMP1 fused to GFP.
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![TFEB Overexpression Induces Lysosomal Exocytosis\
(A) Confocal microscopy images showing the exposure of LAMP1 on the PM in both nonpermeabilized NSC cells and MEFs transfected with either a bicystronic plasmid expressing TFEB-GFP or with an empty vector. LAMP1 was detected using an antibody against its luminal portion (LAMP1-1DB4). TFEB-transfected cells were localized by the expression of GFP; nontransfected cells are indicated by asterisks.\
(B) Quantitative analysis by flow cytometry of LAMP1 levels on the PM in both NSCs and MEFs that express either a bi-cystronic TFEB-GFP plasmid or GFP. Bars represent the fold increase of LAMP1 fluorescence on PM in TFEB-transfected versus GFP-transfected (control) cells.\
(C) TFEB overexpression increases the release of lysosomal enzymes in the culture medium of MEFs, NSCs, HeLa, and COS-7 cells. Activities of lysosomal enzymes acid phosphatase, β-galactosidase, and β-hexosaminidase were determined in the culture medium and in cells transfected with either an empty vector or with a TFEB-expression vector. The figure shows percentages of enzyme activities released compared with total activities.\
(D) Representative immunoblots showing LAMP1 levels in both total lysates and enriched PM extracts from MEFs transfected with either TFEB or with an empty vector. Results were normalized using an antibody against actin and the PM protein β1-integrin, respectively. The histogram shows the quantification of LAMP1 detected by the immunoblot.\
(E) Total and surface LAMP1 levels after TFEB overexpression were analyzed by flow cytometry analyses using the LAMP1-1DB4 and the LAMP1-L1418 antibodies that are able to detect PM- and intracellular-LAMP1, respectively. Data represent mean ± SEM; ^∗^p \< 0.05 (B, C, D, and E). Scale bar represents 10 μm (A).](gr1){#fig1}

![TFEB Enhances Trafficking and PM Proximity of Lysosomes\
(A) TFEB enhances the movement of lysosomes to PM. Merged time-lapse frames of control and stable TFEB-overexpressing HeLa cells (HeLa-CF7) transfected with a LAMP1-GFP vector showing the trajectories of lysosomes. The mean velocity was calculated using IMAGEJ software (see [Experimental Procedures](#sec3){ref-type="sec"} for details).\
(B) Immuno-EM reveals increase in lysosomal exocytosis upon overexpression of TFEB. Control and stable TFEB-overexpressing HeLa cells (HeLa-CF7) were fixed directly or 60 min after addition of 0.5% TA to the medium (see [Experimental Procedures](#sec3){ref-type="sec"}). Then cells were labeled with antibodies against LAMP1 and prepared for immuno-EM (see [Supplemental Experimental Procedures](#app2){ref-type="sec"}). In control HeLa cells, lysosomes decorated by LAMP1 are often detected at a substantial distance from the cell surface (arrows), while treatment with TA only slightly increases the frequency of lysosomes that are close to the PM (arrowheads). TFEB-overexpressing cells (CF7) contain numerous lysosomes located near the cell surface (arrowheads), although several LAMP1-positive structures could be detected toward the cell interior as well (arrow). TA further induced accumulation of lysosomes in subsurface area of TFEB-overexpressing cells with many lysosomes almost touching the PM (arrows). The distance between lysosomes and PM was estimated in thin sections as described in [Experimental Procedures](#sec3){ref-type="sec"} in control and TFEB-overexpressing cells incubated with or without TA (100 lysosomes were counted for each condition). The number of lysosomes, as a function of their distance from the cell surface, was counted over 200 nm intervals (100 lysosomes were counted for each experimental condition). Scale bars represent 10 μm (A) and 350 nm (B). Data represent mean ± SEM; ^∗^p \< 0.05 (A).](gr2){#fig2}

![TFEB-Mediated Induction of Lysosomal Exocytosis Is Associated with Intracellular Ca^2+^ Release\
(A) Analysis of intracellular Ca^2+^ by confocal microscopy of HeLa cells transfected with a bi-cystronic TFEB-GFP construct. Data are displayed as the percentage of cells with Ca^2+^ response compared with the nontransfected cells.\
(B) TFEB overexpression elevates cytosolic Ca^2+^ levels. HeLa cells were infected with either control adenovirus (Ad. Null) or adenovirus expressing TFEB (Ad. TFEB-FLAG) and loaded with Fura-2AM. Cytosolic Ca^2+^ concentration was calculated as described in [Supplemental Experimental Procedures](#app2){ref-type="sec"}.\
(C) TFEB-mediated lysosomal exocytosis is Ca^2+^-dependent. MEFs and HeLa cells transfected with either TFEB or an empty vector were treated with either the Ca^2+^ ionophore ionomycin (10 micromolar) or the membrane-permeable Ca^2+^ chelator BAPTA-AM (30 micromolar), or both. Mean values of cell surface LAMP1 fluorescence were quantified by flow cytometry.\
(D) Ca^2+^ depletion in HeLa-overexpressing TFEB (HeLa CF7) does not affect endolysosomes\' distance to the PM. HeLa q \< CF7 loaded with BSA gold, following the same protocol described in (B), were treated with the Ca^2+^ chelator BAPTA-AM (30 micromolar) for 30 min before the fixation. Morphometric analysis was performed to visualize the distance of endo-lysosomes to the PM. Scale bar represents 10 μm (A). Data represent mean ± SEM; ^∗^p \< 0.05 (A, B, and C).](gr3){#fig3}

![TFEB Elevates Intracellular Ca^2+^ Levels through the Activation of MCOLN1\
(A) Flow cytometric Ca^2+^ flux assay of stable TFEB-transfected HeLa (CF7) and control cells transfected with a vector containing a scramble shRNA or a specific shRNA against MCOLN1. Data represent the mean values of the Fluo3/FuraRed ± SD ratio.\
(B) Flow-cytometry Ca^2+^ flux assay in NSCs transfected with a control vector (CTRL), a vector containing a scramble shRNA plus TFEB plasmid, and a vector containing a specific shRNA against MCOLN1 plus TFEB plasmid. Ca^2+^ was determined in resting condition and after stimulation with ionomycin (10 micromolar).\
(C and D) Analyses of intracellular Ca^2+^ by confocal microscopy of (C) a stable HeLa clone expressing specific shRNA against MCOLN1 (HeLa ^shMCOLN1^) and (D) human MLIV fibroblasts transfected with a bi-cystronic TFEB-GFP construct. Data are displayed as the percentage of cells with Ca^2+^ response compared with nontransfected cells.\
(E) Flow-cytometry analysis of LAMP1 on the PM of HeLa^shMCOLN1^ cells transfected with TFEB.\
(F) Silencing of MCOLN1 reduces TFEB-mediated translocation of LAMP1 to the PM. Representative confocal microscopy images of nonpermeabilized wild-type MEFs transfected with either a bicystronic TFEB-GFP (green in the figure) or with a bi-cystronic TFEB-GFP vector. Cells were cotransfected with a vector containing a specific shRNA against MCOLN1 tagged with RFP (gray in the figure), and stained for luminal LAMP1 (LAMP1-1DB4; red in the figure).\
(G) Secretion of lysosomal β-galactosidase in HeLa^shMCOLN1^ cells. The displayed values represent secretion efficiency of the indicated enzyme, which was calculated as the % of enzymatic activity in the medium with respect to the total activity (medium and cellular pellet). Data represent mean ± SEM; ^∗^p \< 0.05 (A--E and G). Scale bars represent 10 μm (C and F) and 25 μm (D).](gr4){#fig4}

![TFEB Overexpression Reduces Storage in LSD Cells\
(A) NSCs isolated from the cerebral cortex of MSD and MPSIIIA mice were nucleofected with either a TFEB plasmid or with an empty plasmid and cultured on coverslips. Alcian blue was then used to stain the GAGs.\
(B) Wild-type, MSD, and MPSIIIA NSCs were nucleofected either with a TFEB plasmid or with an empty plasmid. After 16 hr, cells were pulsed with H^3^-glucosamine in differentiation medium and chased for the indicated time-points. Cell extracts obtained at different time points were quantified to determine the levels of labeled GAGs.\
(C) Glia-differentiated MSD and MPS-IIIA NSCs were nucleofected with either TFEB or with an empty vector, fixed on glutaraldehyde, and processed for standard electron microscopy. The number of vacuoles per cell was counted from 20 different cells and displayed as mean ± SEM.\
(D) TFEB promotes clearance of lipofuscin in fibroblasts from a patient with Batten disease. Cells were transfected with a vector carrying TFEB-Ruby (continuous red staining). After 24 hr, cells were examined by live imaging confocal analysis. Cells with increased TFEB (i.e., cells with red signal in the picture and outlined by dashed white lines in the middle panel) display highly reduced levels of lipofuscin (punctate green signal) and a normal cellular morphology compared with nontransfected cells (i.e., cells with intense green staining).\
(E) Human Pompe disease fibroblasts were transfected with either TFEB or with an empty vector, loaded with the fluorescent sugar 2-NBDG, and analyzed by epifluorescence microscopy.\
(F) Secretion efficiency of radioactive GAGs was measured in the culture medium of NSCs from MSD mice. Cells were nucleofected with either TFEB or an empty vector after pulse-chase incorporation of H^3^-glucosamine. Scale bars represent 100 μm (A), 10 μm (C, MSD cells), 500 nm (C, MPSIIIA cells), and 10 μm (D). Data represent mean ± SEM; ^∗^p \< 0.05 (B, C, and F).](gr5){#fig5}

![TFEB Overexpression Reduces Storage and Tissue Pathology in a Mouse Model of MSD\
(A) Alcian blue staining of GAG content in skeletal muscle and liver from mice injected systemically with either an AAV2/9-CMV-GFP or with an AAV2/9-CMV-TFEB3xflag viral vector.\
(B) Quantitative analysis of GAG content in skeletal muscle and liver of MSD mice injected with either an AAV2/9-CMV-GFP or with an AAV2/9-CMV-TFEB3xflag viral vector. GAG content was displayed as mg of GAGs/mg of tissue extract. At least four mice per group were analyzed for each tissue examined (^∗^p \< 0.05). Data are mean ± SEM.\
(C) TFEB reduces inflammation in the liver of MSD mice. Macrophages and macrophage-related inflammatory cells were detected in liver sections from mice injected systemically with either an AAV2/9-CMV-GFP or with an AAV2/9-CMV-TFEB3xflag viral vector by immunofluorescence analysis using an antibody against CD68.\
(D) Reduction of TUNEL-positive cells (arrows) in 4-month-old MSD mice injected with an AAV2/9-CMV-TFEB3xflag viral vector compared with age-matched MSD noninjected mice. At least four mice per group were analyzed for each tissue examined). Data are mean ± SEM; ^∗^p \< 0.05 (B and D). Scale bars represent 100 μm (A, C, and D).](gr6){#fig6}
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